Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness.
Messina, Monica; Del Giudice, Ilaria; Khiabanian, Hossein; Rossi, Davide; Chiaretti, Sabina; Rasi, Silvia; Spina, Valeria; Holmes, Antony B; Marinelli, Marilisa; Fabbri, Giulia; Piciocchi, Alfonso; Mauro, Francesca R; Guarini, Anna; Gaidano, Gianluca; Dalla-Favera, Riccardo; Pasqualucci, Laura; Rabadan, Raul; Foà, Robin.
; 123(15): 2378-88, 2014 Apr 10.
Artigo em Inglês | MEDLINE | ID: mdl-24550227
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.
Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact.
PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL).
Sensitizing protective tumor microenvironments to antibody-mediated therapy.
Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia.
CLLonal selection: survival of the fittest?
State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.
Proteomics insights into the pathology and prognosis of chronic lymphocytic leukemia.
The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience.